Last reviewed · How we verify

Proglycem — Competitive Intelligence Brief

Proglycem (DIAZOXIDE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: diazoxide. Area: Metabolic.

marketed diazoxide Sulfonylurea receptor 1, Kir6.2 Metabolic Small molecule Live · refreshed every 30 min

Target snapshot

Proglycem (DIAZOXIDE). Proglycem works by blocking the ATP-sensitive potassium channel, which helps to increase blood sugar levels and reduce insulin secretion.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Proglycem TARGET DIAZOXIDE marketed diazoxide Sulfonylurea receptor 1, Kir6.2 1973-01-01
Starlix NATEGLINIDE Novartis marketed Glinide [EPC] Sulfonylurea receptor 1, Kir6.2 2000-01-01
Amaryl GLIMEPIRIDE Sanofi marketed Sulfonylurea [EPC] Sulfonylurea receptor 1, Kir6.2 1995-01-01
Micronase glibenclamide Sanofi marketed Sulfonylurea Sulfonylurea receptor 1, Kir6.2 1984-01-01
Glucotrol GLIPIZIDE Pfizer marketed Sulfonylurea [EPC] Sulfonylurea receptor 1, Kir6.2 1984-01-01
Dymelor ACETOHEXAMIDE Eli Lilly marketed acetohexamide Sulfonylurea receptor 1, Kir6.2 1964-01-01
Aglicid TOLBUTAMIDE marketed Sulfonylurea Sulfonylurea receptor 1, Kir6.2 1961-01-01

Recent regulatory actions (last 90 days)

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (diazoxide class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Proglycem — Competitive Intelligence Brief. https://druglandscape.com/ci/diazoxide. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: